Efficacy of niraparib by time of surgery and postoperative residual disease status: A post hoc analysis of patients in the PRIMA/ENGOT-OV26/GOG-3012 study
Gynecol Oncol (in press)
DOI 10.1016/j.ygyno.2022.04.012, PubMed 35550709
Clinicopathological prognostic parameters in patients with tubo-ovarian carcinoma effusions
Cytopathology (in press)
DOI 10.1111/cyt.13126, PubMed 35398934
Time to first recurrence, pattern of recurrence, and survival after recurrence in endometrial cancer according to the molecular classification
Gynecol Oncol, 165 (2), 230-238
DOI 10.1016/j.ygyno.2022.02.024, PubMed 35277281